Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Pharming Group NV (PHGUF) had Debt to Capital Ratio of 0.31 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$97.30M |
|
$7.50M |
|
$7.10M |
|
$90.20M |
|
$81.50M |
|
$15.80M |
|
$-3.10M |
|
$12.70M |
|
$12.70M |
|
$7.50M |
|
$7.50M |
|
$7.50M |
|
$7.50M |
|
$15.80M |
|
$18.53M |
|
681.82M |
|
681.82M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$277.60M |
|
$7.47M |
|
$196.19M |
|
$473.79M |
|
$87.91M |
|
$121.23M |
|
$121.23M |
|
$209.14M |
|
$264.64M |
|
$129.72M |
|
$264.64M |
|
680.31M |
|
| Cash Flow Statement Financials | |
$44.00M |
|
$26.30M |
|
$0.46M |
|
$54.94M |
|
$132.37M |
|
$77.43M |
|
$9.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.16 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.31 |
0.49 |
|
92.70% |
|
16.24% |
|
16.24% |
|
-- |
|
13.05% |
|
7.71% |
|
$43.52M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.11 |
|
2.23 |
|
40.33 |
|
2.83% |
|
5.78% |
|
1.58% |
|
1.94% |
|
$0.39 |
|
$0.06 |
|
$0.06 |
|